How should we advise patients about the contraceptive patch, given the FDA warning?
Holly L. Thacker, MD
Director, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case-Western Reserve University
Tommaso Falcone, MD
Chairman, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case-Western Reserve University
Ashish Atreja, MD, MPH
Associate Program Director, Medical Informatics Fellowship, Department of General Internal Medicine, The Cleveland Clinic Foundation
Anil Jain, MD
Department of General Internal Medicine, The Cleveland Clinic Foundation
C. Martin Harris, MD, MBA
Chief Information Officer, Chairman, Information Technology Division, Department of Internal Medicine, The Cleveland Clinic Foundation
Address: Holly L. Thacker, MD, Gault Women’s Health and Breast Pavilion, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail thackeh@ccf.org